Galapagos | L'Utile Operativo



Operating Profit Cambiamento Data
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Biogen USD 441.4M 24.4M 2024-12
Genmab DKK 2.19B 89M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Incyte USD 205.17M 96.34M 2025-03
Merck EUR 1.2B 100M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 163M 39M 2024-06
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Galapagos L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.